These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23979444)

  • 1. [Statement on Porzsolt in "monitor healthcare research"].
    Rettig-Stürmer G; Schieffer H; Müller E
    Urologe A; 2014 Mar; 53(3):390. PubMed ID: 23979444
    [No Abstract]   [Full Text] [Related]  

  • 2. The statistician and the data monitoring committee.
    D'Agostino RB
    Stat Med; 2004 May; 23(10):1501-2. PubMed ID: 15122726
    [No Abstract]   [Full Text] [Related]  

  • 3. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
    Ellenberg SS; George SL
    Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees.
    Wells RJ; Gartside PS; McHenry CL
    IRB; 2000 Jan; 22(1):7-11. PubMed ID: 12546010
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical considerations in industry-sponsored multiregional clinical trials.
    Ibia E; Binkowitz B; Saillot JL; Talerico S; Koerner C; Ferreira I; Agarwal A; Metz C; Maman M
    Pharm Stat; 2010; 9(3):230-41. PubMed ID: 20824884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The independent statistician for data monitoring committees.
    DeMets DL; Fleming TR
    Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dilemma of data-safety monitoring: provision of significant new data to research participants.
    Peppercorn J; Buss WG; Fost N; Godley PA
    Lancet; 2008 Feb; 371(9611):527-9. PubMed ID: 18262043
    [No Abstract]   [Full Text] [Related]  

  • 8. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
    Perlis CS; Harwood M; Perlis RH
    J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How skeptical should we be about industry-sponsored studies?
    Meador KJ
    Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
    [No Abstract]   [Full Text] [Related]  

  • 10. Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network.
    Pirotta M; Chondros P;
    Aust Fam Physician; 2004 Nov; 33(11):950-1, 956. PubMed ID: 15584339
    [No Abstract]   [Full Text] [Related]  

  • 11. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data safety monitoring boards: legal and ethical considerations for research accountability.
    Tereskerz PM
    Account Res; 2010 Jan; 17(1):30-50. PubMed ID: 20094929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data and safety monitoring boards: academic credit where credit is due?
    Armstrong PW; Califf RM
    JAMA; 2013 Oct; 310(15):1563-4. PubMed ID: 24129461
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflict of interest: will it ever end?
    Carney SL
    Intern Med J; 2012 Nov; 42(11):1255-6. PubMed ID: 23157520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-study availability of investigational treatments.
    Mann H; Djulbegovic B
    Lancet; 2003 Apr; 361(9365):1302. PubMed ID: 12699986
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conflict of interest: the World Medical Association statement].
    Fialová L; Spacek M; Vychytil P
    Cas Lek Cesk; 2011; 150(10):554-7. PubMed ID: 22132627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many moral responsibilities of independent data-monitoring committees.
    Braillon A
    Am J Bioeth; 2011 Mar; 11(3):16-7. PubMed ID: 21400378
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict of interest--or conflict of priorities?
    Nabel EG
    N Engl J Med; 2006 Nov; 355(22):2365-7. PubMed ID: 17135592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.